Adagene, Inc. (ADAG)
2.58
+0.09
(+3.61%)
USD |
NASDAQ |
Oct 27, 16:00
2.58
0.00 (0.00%)
After-Hours: 20:00
Adagene Market Cap : 173.23M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 167.19M |
| October 23, 2026 | 161.82M |
| October 22, 2026 | 163.83M |
| October 21, 2026 | 161.82M |
| October 20, 2026 | 167.86M |
| October 19, 2026 | 153.76M |
| October 16, 2026 | 138.32M |
| October 15, 2026 | 161.14M |
| October 14, 2026 | 153.76M |
| October 13, 2026 | 165.17M |
| October 12, 2026 | 183.97M |
| October 09, 2026 | 185.32M |
| October 08, 2026 | 186.66M |
| October 07, 2026 | 188.67M |
| October 06, 2026 | 196.73M |
| October 05, 2026 | 188.00M |
| October 02, 2026 | 191.36M |
| October 01, 2026 | 196.73M |
| September 30, 2026 | 214.86M |
| September 29, 2026 | 215.53M |
| September 28, 2026 | 214.86M |
| September 25, 2026 | 196.73M |
| September 24, 2026 | 200.09M |
| September 23, 2026 | 199.42M |
| September 22, 2026 | 216.87M |
| Date | Value |
|---|---|
| September 21, 2026 | 215.53M |
| September 18, 2026 | 222.24M |
| September 17, 2026 | 226.27M |
| September 16, 2026 | 212.84M |
| September 15, 2026 | 199.42M |
| September 14, 2026 | 219.56M |
| September 11, 2026 | 228.29M |
| September 10, 2026 | 222.24M |
| September 09, 2026 | 219.56M |
| September 08, 2026 | 234.33M |
| September 04, 2026 | 240.37M |
| September 03, 2026 | 247.76M |
| September 02, 2026 | 247.76M |
| September 01, 2026 | 244.40M |
| August 31, 2026 | 235.67M |
| August 28, 2026 | 247.09M |
| August 27, 2026 | 261.86M |
| August 26, 2026 | 258.50M |
| August 25, 2026 | 256.49M |
| August 24, 2026 | 261.86M |
| August 21, 2026 | 269.92M |
| August 20, 2026 | 274.62M |
| August 19, 2026 | 276.63M |
| August 18, 2026 | 271.93M |
| August 17, 2026 | 257.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascletis Pharma, Inc. | 770.14M |
| CStone Pharmaceuticals Co. Ltd. | 1.201B |
| RemeGen Co., Ltd. | 5.586B |
| InnoCare Pharma Ltd. | 2.823B |
| JW (Cayman) Therapeutics Co. Ltd. | 82.08M |
Market Cap Related Metrics
| PS Ratio | 14.40 |
| Price | 2.58 |
| Earnings Yield | -14.63% |